United States · FDA National Drug Code directory
ROPIVACAINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70512-798_45729174-5a1c-aa47-e063-6294a90af039
- Product NDC
- 70512-798
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ROPIVACAINE HYDROCHLORIDE
- Labeler
- SOLA Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241201
- Source listing expiry
- 20261231
Source-listed ingredients
- ROPIVACAINE HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 24 BAG in 1 CARTON (70512-798-24) / 200 mL in 1 BAG (70512-798-01) · 70512-798-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →